Corcept Therapeutics Incorporated (CORT)

Fixed asset turnover

		Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019	Jun 30, 2019	Mar 31, 2019
Revenue (ttm)	US$ in thousands	482,375	450,026	428,153	413,824	401,858	397,624	392,027	380,229	365,978	352,891	343,087	340,064	353,874	356,034	351,212	334,904	306,486	285,422	268,362	258,417
Property, plant and equipment	US$ in thousands	195	302	413	461	633	801	862	726	1,002	1,226	1,414	1,481	1,675	1,311	619	880	1,050	1,227	1,177	925
Fixed asset turnover		2,473.72	1,490.15	1,036.69	897.67	634.85	496.41	454.79	523.73	365.25	287.84	242.64	229.62	211.27	271.57	567.39	380.57	291.89	232.62	228.01	279.37

December 31, 2023 calculation

Fixed asset turnover = Revenue (ttm) ÷ Property, plant and equipment
= $482,375K ÷ $195K
= 2,473.72

The fixed asset turnover ratio for Corcept Therapeutics Inc has seen a fluctuating trend over the past eight quarters. The ratio measures the company's ability to generate sales based on its investment in fixed assets. A higher fixed asset turnover ratio indicates that the company is utilizing its fixed assets efficiently to generate revenue.

In Q4 2023, the fixed asset turnover ratio was significantly high at 2,473.72, reflecting a strong efficiency in generating sales from fixed assets. This was a sharp increase from the previous quarter's ratio of 1,490.15 in Q3 2023.

The trend over the past quarters shows that the fixed asset turnover ratio has been gradually increasing since Q1 2022, with some fluctuations along the way. The ratio peaked in Q4 2023, indicating an improvement in the company's efficiency in utilizing its fixed assets to generate revenue.

Overall, the increasing trend in the fixed asset turnover ratio suggests that Corcept Therapeutics Inc has been effectively managing and utilizing its fixed assets to drive sales growth, which is a positive indicator for the company's operational performance.